FDA Inspection 1094836 — Sanofi-Aventis Deutschland GmbH

Sanofi-Aventis Deutschland GmbH — FEI 3003195501

The FDA completed an inspection of Sanofi-Aventis Deutschland GmbH on May 14, 2019 in Frankfurt Am Main. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 14, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Frankfurt Am Main (Germany)